T2 Biosystems

(OTC) TTOO

Current Price$0.00

Market Cap$11,200

Since IPO (2014)-100%

5 Year-100%

1 Year-97%

1 Month+1,400%

T2 Biosystems Financials at a Glance

Market Cap

$11,200

Revenue (TTM)

$7.68M

Net Income (TTM)

$42.95M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-0.41 (Low)

Dividend

$0.00

Beta (Volatility)

-0.41 (Low)

Price

$0.00

Volume

11,562

Open

$0.00

Price

$0.00

Volume

11,562

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.18

Dividend

$0.00

Beta (Volatility)

-0.41 (Low)

Price

$0.00

Volume

11,562

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.18

TTOO News

using a stethoscope listen to the heartbeat of patient

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About T2 Biosystems

Industry

Biotechnology

Sector

Health Care

Employees

113

CEO

John J. Sperzel, III

Website

www.t2biosystems.com

Headquarters

Lexington, MA 02421, US

TTOO Financials

Key Financial Metrics (TTM)

Gross Margin

-1%

Operating Margin

-7%

Net Income Margin

-7%

Return on Equity

Return on Capital

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$11.20K

Shares Outstanding

28.05M

Volume

11.56K

Avg. Volume

7.23K

Financials (TTM)

Gross Profit

$8.17M

Operating Income

$49.66M

EBITDA

$43.88M

Operating Cash Flow

$48.14M

Capital Expenditure

$192.00K

Free Cash Flow

$48.33M

Cash & ST Invst.

$15.69M

Total Debt

$49.50M

T2 Biosystems Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2024YOY CHG

Revenue

$1.99M

+34.9%

Gross Profit

$2.12M

+13.7%

Gross Margin

-1.07%

N/A

Market Cap

$11.20K

N/A

Market Cap/Employee

$99.12

N/A

Employees

113

N/A

Net Income

$10.12M

+34.4%

EBITDA

$9.69M

+31.0%

Quarterly Fundamentals

Name

Q3 2024YOY CHG

Net Cash

$16.86M

+33.0%

Accounts Receivable

$2.03M

+78.5%

Inventory

$3.83M

-10.7%

Long Term Debt

$5.30M

-24.6%

Short Term Debt

$13.65M

-69.0%

Return on Assets

-1.44%

N/A

Return on Invested Capital

2.33%

N/A

Free Cash Flow

$6.25M

+53.4%

Operating Cash Flow

$6.25M

+53.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TEVNFTevano Systems Holdings Inc.

TEVNFTevano Systems Holdings Inc.$0.00+0.00%

IPIXInnovation Pharmaceuticals Inc.

IPIXInnovation Pharmaceuticals Inc.$0.00+0.00%

LFCOFLift & Co. Corp.

LFCOFLift & Co. Corp.$0.00+0.00%

MDINMedGen, Inc.

MDINMedGen, Inc.$0.00+0.00%

AOXGAoxing Pharmaceutical Company, Inc.

AOXGAoxing Pharmaceutical Company, Inc.$0.00+0.00%

PDMIParadigm Medical Industries, Inc.

PDMIParadigm Medical Industries, Inc.$0.00+0.00%

WSNAFWesana Health Holdings Inc.

WSNAFWesana Health Holdings Inc.$0.02+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SOFISoFi Technologies

SOFISoFi Technologies$15.53-0.15%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.14+0.04%

HOODRobinhood Markets

HOODRobinhood Markets$71.20-0.13%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$61.86+0.02%

KALVKalVista Pharmaceuticals

KALVKalVista Pharmaceuticals$26.67+0.39%

POETPoet Technologies

POETPoet Technologies$6.60-0.18%

ONDSOndas

ONDSOndas$9.49-0.09%

Questions About TTOO

What is the current price of T2 Biosystems?

T2 Biosystems is trading at $0.00 per share.

What is the 52-week range for T2 Biosystems?

Over the past 52 weeks, T2 Biosystems has traded between $0.00 and $0.18.

How much debt does T2 Biosystems have?

As of the most recent reporting period, T2 Biosystems reported total debt of $18.94M.

How much cash does T2 Biosystems have on hand?

T2 Biosystems reported $2.08M in cash and cash equivalents in its most recent financial results.

What is T2 Biosystems’s dividend yield?

T2 Biosystems does not currently have a dividend yield.

T2 Biosystems

T2 Biosystems Financials at a Glance

TTOO News

Why Shares of T2 Biosystems Are Falling Friday

Why T2 Biosystems Stock Soared Today

Why T2 Biosystems Stock Is Soaring Today

Here's Why T2 Biosystems Rose as Much as 16% Today

Here's Why T2 Biosystems, Inc. Rose Over 16% Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About T2 Biosystems

TTOO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

T2 Biosystems Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TTOO

What is the current price of T2 Biosystems?

What is the 52-week range for T2 Biosystems?

How much debt does T2 Biosystems have?

How much cash does T2 Biosystems have on hand?

What is T2 Biosystems’s dividend yield?

Premium Investing Services